Fundraising FoxVIVES Partners
Venture capitalWavre · Pre-Seed–Growth · 4 people tracked
Find your way into VIVES Partners
718 people in our graph share verified history with the VIVES Partners team — schools, employers, funds. One of them is your warm intro.
Investment thesis
VIVES is a multi-sector technology fund focused on backing spin-offs from UCLouvain as well as startups in Belgium and neighbouring European countries. It invests across the development stages of a company, from seed and startup phases through to growth. The fund states it only invests in companies located in Europe, and its portfolio spans biotech, pharma, medtech, agtech/agri, and engineering/IT sectors.
Source: firm website, verified Sep 27, 2026.
Team · 4 people
from public directories
What they invest in
from 19 of 35 portfolio companiesBiotech ×13Healthtech ×9Medical Devices ×8Deep Tech ×7AI & Machine Learning ×5AgTech ×4Digital Health ×3SaaS ×3
HQs:Belgium×10United States×2Switzerland×1Netherlands×1
Who they back
founder profiles across 9 portfolio companiesFounding team size:solo founder×52 founders×33 founders×1
Investments · 35 tracked
founders shown can be your intro pathBy year:2026 · 12024 · 12020 · 13 dated
ATB Therapeutics is a biotech company developing bispecific antibody therapies and related immunological treatments.
BiotechHealthtechMedical Devices
Dr. Mark Throsby(Chief Executive Officer)
Co-investorsMRL Ventures FundV-Bio VenturesEQT Life SciencesSambrinvestWallonie EntreprendreEQT
Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation mono and multispecific antibodies for severe immune-mediated inflammatory diseases, with an initial focus on atopic dermatitis and inflammatory bowel disease.
BiotechHealthtech
Frédéric Marrache(Co-founder & CEO)in
Co-investorsJeito CapitalSanofi VenturesSofinnova PartnersApollo Health VenturesSixty Degree Capital
3D-Side develops a web-based platform called Customize that connects surgeons, patients, and medical device manufacturers to plan, design, and supervise production of patient-specific medical devices for surgical applications.
Advanced ManufacturingAI & Machine LearningDigital HealthMedical DevicesSaaSBrussels, BE
Aphea.Bio develops bioinsecticides targeting sap-sucking insects that damage crops, in partnership with Bayer to accelerate their development.
AgTechBiotech
Isabel Vercauterenin
Co-investorsAstanor VenturesEuropean Circular Bioeconomy FundInnovation IndustriesPMVV-Bio VenturesAIF+2 more
Axinesis develops CE-marked robotic rehabilitation devices for patients with motor and cognitive disorders across acute and home-care settings.
Digital HealthHealthtechMedical DevicesRobotics
Julien Sapin(Founder & CTO)inPieter Van den Steen(CEO)in
Co-investorsNivelinvest
BioCsol develops engineered formulations combining active compounds with complementary mechanisms of action for agricultural use, delivering biodegradable solutions that protect soil health while preventing resistance.
AgTechBiotechCircular EconomyCleantechLouvain-la-Neuve, BE
Denis Payenin
Co-investorsAgri Investment Fund
Botalys develops a platform for creating rare botanical ingredients tailored for nutraceutical and cosmetic applications through structured co-development partnerships with industry leaders.
AgTechBiotechDeep TechHealthtechWellness & FitnessBelgium, BE
Pierre-Antoine Mariage(CEO & Co-founder)
Co-investorsAir Liquide Venture Capital (ALIAD)MirovaThe Yield LabThe Yield Lab Europe
e-peas develops energy harvesting power management ICs (ambient energy managers) and low-power microcontrollers that improve the autonomy of intelligent devices for markets including smart home, consumer electronics, and industrial IoT.
EnergyHardwareIoTSemiconductorsLouvain-la-Neuve, BE
Geoffroy Gosset(CEO & Co-founder)inJulien De Vos(CTO & Co-founder)inChristian Ferrier(CMO - Chief Marketing Officer)inCoralie Brancart(CFO - Chief Financial Officer)Abdelali Lotfi(Sr VP Operations and Global Supply)
Co-investorsNivelinvestAirbus VenturesCrédit Mutuel EquityWallonie EntreprendreOtium CapitalWING by Digital Wallonia
Eligo Bioscience is a genetic engineering company pioneering synthetic biology approaches using CRISPR and phage biology to develop therapeutics.
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
David Bikard(Scientific Founder)Benoit Barteau(Scientific Cofounder)Nessan Bermingham(Scientific Cofounder)Laia Crespo-Martin(Scientific Cofounder)Xavier Duportet(CEO)
Co-investorsAgoranovNSG VenturesSanofi VenturesSeventure Partners
ExeVir develops multi-specific VHH antibody therapies to treat infectious diseases, immunological conditions, and oncology, with a focus on immunocompromised populations.
BiotechDeep TechDigital HealthHealthtechMedical DevicesGhent, BE
Xavier Saelens(Scientific Founder)Nico Callewaert(Scientific Founder)inMike Garrett(Chief Executive Officer)
Co-investorsV-Bio VenturesSambrinvestUCB VenturesVIBFund+
Generare is building a library of naturally evolved molecules by reading and analyzing biological chemistry that has not been previously studied.
AI & Machine LearningBiotech
Co-investorsAgoranovDaphniGalion.exeTeampact.venturesAlven
Keemotion provides automated video capture and analysis technology for sports teams to record and analyze game performance through comprehensive analytics and scouting tools.
AI & Machine LearningCloud ComputingMedia & EntertainmentSaaSSports Tech
Co-investorsR/GA VenturesElysian Park Ventures
Axoneurotech develops neural engineering technology using a biology-first approach at the intersection of biology and engineering.
BiotechDeep TechMedical Devices
Co-investorsFifty Years
Novadip develops regenerative medicine treatments using its 3M3 tissue regeneration platform to address conditions requiring bone and tissue repair, including spinal fusion, cancer recovery, and complex fractures.
BiotechDeep TechHealthtechMedical DevicesLouvain, BE
Dr. Denis Dufrane(Founder & Professor)in
BoardEric Paul Pâques(Chairman)
Co-investorsNew Science VenturesFund+SambrinvestWallonie Entreprendre
Nuclidium develops copper-based radioligand therapeutics and diagnostics for cancer treatment and diagnosis, with programs targeting prostate and breast cancer using Copper-61 and Copper-67 isotopes.
BiotechDeep TechHealthtechMedical DevicesBasel, CH
Leila Jaafar(CEO)Gustav(Medical Advisor)
Co-investorsAngelini VenturesDeepTech & Climate FondsKurma PartnersNeva Sgr.
Sunrise AI designs, deploys, and operates custom AI systems inside client businesses, connecting to their proprietary data and workflows to build an "AI operating layer" starting with a single high-impact workflow.
AI & Machine LearningEnterprise SoftwareSaaS
Co-investorsAI FundSambrinvestSeventure PartnersKurma Partners
The Akkermansia Company produces a consumer dietary supplement containing proprietary Akkermansia MucT™ bacteria formulated to support weight management, glucose metabolism, gut health, and immune function.
BiotechDirect to ConsumerHealthtechLongevityWellness & Fitness
Muriel DerrienWillem M. de Vos(Chair of Microbiology, Wageningen University)
Co-investorsInnovation IndustriesSeventure Partners
Vocsens develops a gas sensor product called Envicam-30 that uses semiconductor technology with ultra-low power consumption and a matrix of 16 sensing material spots, addressing the cost and maintenance challenges of traditional gas sensing systems.
CleantechDeep TechHardwareIoTSemiconductorsLouvain-la-Neuve, BE
Laurent Francis(Prof.)Denis Flandre(Prof.)Jean-Pierre Raskin(Prof.)
Co-investorsAgri Investment FundAIF
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
BrightflowCISSOIDEligo BiosciencesEmolyticsGreenWattIntoPIXiTeos TherapeuticsLMOPromethera BiosciencesSmartNodesSpinovitSyndesi TherapeuticsTessaresUpstreemViroVetVIVES IUF
Portfolio news
latest coverage across their companiesAphea · agfundernews.com · Jun 11, 2026
Frequently asked questions
- How many investments has VIVES Partners made?
- VIVES Partners has 35 tracked investments, including 2 dated in the last 24 months.
- What stage does VIVES Partners invest at?
- VIVES Partners invests at the Pre-Seed, Seed, Series A, Series B, Growth stages.
- What is VIVES Partners's typical check size?
- VIVES Partners typically writes checks of $108K – $7.6M.
- What sectors does VIVES Partners focus on?
- VIVES Partners focuses on AgTech, Biotech, Cleantech, Climate Tech, Deep Tech, FoodTech, Hardware, Healthtech, IoT, Medical Devices, Sector Agnostic, Semiconductors.
- Where is VIVES Partners located?
- VIVES Partners is headquartered in Wavre, BE.
- Who does VIVES Partners co-invest with?
- VIVES Partners most often shares deals with Agri Investment Fund, Fund+, Nivelinvest, among 26 tracked co-investors.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
UntroD Capital manages the RealTech Fund family, supplying capital to research-and-development-driven deep tech startups working on planetary and societal challenges, providing lead investment and hands-on support from seed and early stages.
Clave is a private equity/venture capital manager with 20 years of experience and more than 90 investments made, actively participating in the strategy and management of its portfolio companies.
Innovation Industries is a Dutch deep-tech venture capital firm that builds and scales technology companies through hands-on, multidisciplinary support.
This page is the analysis and research library of BDC (Business Development Bank of Canada), listing studies, surveys and reports on issues affecting Canadian small and medium-sized businesses and the venture capital landscape.